InvestSMART

Botanix Pharmaceuticals Ltd (ASX: BOT) - Announcements

Current share price for BOT : $0.009 0.001 (10%)+

ASX company news and announcements for Botanix Pharmaceuticals Ltd (BOT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Botanix Pharmaceuticals Ltd (BOT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Botanix Pharmaceuticals Ltd (BOT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Botanix Pharmaceuticals Ltd (BOT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Botanix Provides Retraction in Presentation 16 May 2019 1:29PM $0.110 $0.009 fallen by 91.82%
$25 Trading Halt 16 May 2019 11:24AM $0.110 $0.009 fallen by 91.82%
$25 Pause In Trading 16 May 2019 11:06AM $0.110 $0.009 fallen by 91.82%
$25 Botanix Presenting at Canaccord Genuity Cannabis Conference 14 May 2019 5:53PM $0.100 $0.009 fallen by 91%
$25 Appendix 4C - Quarterly 30 Apr 2019 5:17PM $0.100 $0.009 fallen by 91%
$25 Appendix 3B 18 Apr 2019 6:11PM $0.105 $0.009 fallen by 91.43%
$25 Appendix 3B and Notice Under Section 708A 18 Mar 2019 3:26PM $0.115 $0.009 fallen by 92.17%
$25 Details of Company Address 13 Mar 2019 8:13PM $0.115 $0.009 fallen by 92.17%
$25 Updated Investor Presentation 4 Mar 2019 12:17PM $0.115 $0.009 fallen by 92.17%
$25 Opinion Leaders Present Botanix Data at AAD 2019 4 Mar 2019 8:41AM $0.115 $0.009 fallen by 92.17%
$25 Appendix 3B 28 Feb 2019 7:45PM $0.110 $0.009 fallen by 91.82%
$25 Half Yearly Report and Accounts 28 Feb 2019 5:05PM $0.110 $0.009 fallen by 91.82%
$25 Permetrex Outperforms Other CBD Topical Products 26 Feb 2019 9:58AM $0.115 $0.009 fallen by 92.17%
$25 Change of Director's Interest Notice SW 26 Feb 2019 9:39AM $0.115 $0.009 fallen by 92.17%
$25 Appendix 3B 22 Feb 2019 9:41AM $0.110 $0.009 fallen by 91.82%
$25 Initial Director's Interest Notice SW 21 Feb 2019 7:12PM $0.110 $0.009 fallen by 91.82%
$25 Appointment of Non-Executive Chairman Dr Stewart Washer 21 Feb 2019 10:00AM $0.105 $0.009 fallen by 91.43%
$25 Initial Director's Interest Notice MT 15 Feb 2019 9:36AM $0.097 $0.009 fallen by 90.72%
$25 Appointment of Executive Director Dr Michael Thurn 12 Feb 2019 9:53AM $0.100 $0.009 fallen by 91%
$25 Final Director's Interest Notice 11 Feb 2019 6:28PM $0.100 $0.009 fallen by 91%
$25 Passing of Non-Executive Chairman Mr Graham Griffiths 8 Feb 2019 9:38AM $0.095 $0.009 fallen by 90.53%
$25 2019 Outlook Presentation 31 Jan 2019 10:38AM $0.097 $0.009 fallen by 90.72%
$25 Appendix 4C - Quarterly 31 Jan 2019 10:35AM $0.097 $0.009 fallen by 90.72%
$25 Investigators Meeting Completed for BTX 1204 Phase 2 Study 25 Jan 2019 9:39AM $0.086 $0.009 fallen by 89.53%
$25 Ethics Approval for Phase 2 Atopic Dermatitis Study Received 18 Dec 2018 9:43AM $0.070 $0.009 fallen by 87.14%

551 - 575 of 726 results

Page 23 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.